TCP
BHC icon

Tourbillon Capital Partners’s Bausch Health BHC Stock Holding History

Tourbillon Capital Partners’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-860,000
Closed -$22.6M – 61
2016
Q1 		$22.6M Buy
+860,000
New +$63.6M 0.49% 40

Other funds holding BHC

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tourbillon Capital Partners's BHC Position: Q2 2016 in Review

Tourbillon Capital Partners sold out of Bausch Health (BHC) in Q2 2016, closing a stake of 3,415,000 shares — an estimated $96.7M sold.

Tourbillon Capital Partners first reported a position in BHC in Q4 2014 and held it in 3 quarters. The position peaked at $112M in Q4 2014. 347 funds tracked by Wall St. Rank hold BHC as of Q2 2016.

  • Tourbillon Capital Partners reported no remaining Bausch Health position as of Q2 2016 after selling out during the quarter.
  • Tourbillon Capital Partners sold 3,415,000 Bausch Health shares in Q2 2016, an estimated $96.7M.
  • Tourbillon Capital Partners first reported a position in Bausch Health in Q4 2014 and held it in 3 quarters.
  • Tourbillon Capital Partners's Bausch Health position peaked at $112M in Q4 2014.
  • 347 funds tracked by Wall St. Rank held Bausch Health as of Q2 2016.

Based on Tourbillon Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.